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THE ACCURACY OF DIAGNOSIS OF MAJOR DEPRESSION  
IN PATIENTS WITH PARKINSON’S DISEASE
A comparative study among the updrs, the Geriatric 
depression scale and the Beck depression Inventory
Vitor Tumas1, Guilherme Gustavo Ricioppo Rodrigues2, 
Tarsis Leonardo Almeida Farias2, José Alexandre S. Crippa1
Abstract – Objective: Evaluate the accuracy of diagnosis of major depression in patients with parkinson’s disease 
(pd) using the updrs, the 15-item Geriatric depression scale (Gds15) and the Beck depression Inventory 
(BdI).  Method: 50 consecutive patients with pd were evaluated. The diagnosis of major depression was made 
according to the dsM-IV criteria.  Results: We found a 24% prevalence of major depression. All depression 
scales were highly correlated but updrs depression item had the lowest diagnostic value. The Gds15 had the 
more appropriate “receiver operating characteristics” curve. The best cut-off scores for screening depression 
were 17/18 for BdI and 8/9 for Gds15. We did not find any correlation between the level of depression and 
intensity of motor symptoms, functional capacity and duration of the disease.  Conclusion: Gds15 is better 
than the BdI and the updrs for screening depression in pd and depression is not related to the degree of 
parkinsonian symptoms.
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A precisão do diagnóstico de depressão na doença de Parkinson: um estudo comparativo entre a UPDRS, 
a Escala Geriátrica de Depressão e o Inventário de Depressão de Beck
Resumo – Objetivo: Avaliar a precisão do diagnóstico de depressão em pacientes com doença de parkinson 
avaliados pela updrs, pela Escala Geriátrica de depressão com 15 itens (EGd15) e pelo Inventário de depressão 
de Beck (IdB).  Método: 50 pacientes com dp foram avaliados. O diagnóstico de depressão maior foi feito 
segundo os critérios do dsM-IV.  Resultados: A prevalência de depressão foi 24%. As escalas de depressão tiveram 
elevada correlação entre si. A updrs apresentou a menor sensibilidade para o diagnóstico. A EGd15 mostrou 
uma curva rOC mais apropriada que o IdB. Os melhores escores-de-corte para diagnóstico de depressão foram 
17/18 para o IdB e 8/9 para a EGd15. Não houve correlação entre os níveis de depressão e a intensidade do 
parkinsonismo, a capacidade funcional ou a duração da doença.  Conclusão: A EGd15 é melhor que o IdB para 
diagnosticar depressão na dp. A depressão não está relacionada à gravidade dos sintomas parkinsonianos.
pALAVrAs-CHAVE: depressão, doença de parkinson, updrs, Escala Geriátrica de depressão, Inventário de 
depressão de Beck.
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depression is a frequent co-morbidity affecting 
around 20% to 40% of patients with parkinson’s disease 
(pd)1. Moreover, depression is also pointed as one of the 
most important factors impairing the quality of life of 
patients and their caregivers2,3. despite its clinical sig-
nificance, depression still remains as an underdiagnosed 
problem in patients with pd4. 
One reason for that may be the little attention given 
for this problem during the clinical evaluation. The uni-
fied parkinson’s disease rating scale (updrs) dedicates 
only one item to evaluate depression5. The clinician rates 
his clinical impression after a free medical interview and 
grades depression subjectively at 4 levels of severity. To 
our knowledge, the reliability and validity of the updrs 
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to diagnose and grade depression had never been evalu-
ated, but is expected to be far from perfect. One strate-
gy to improve the diagnosis of depression is to make use 
of self-reporting scales.
On this basis, we decided to investigate the accura-
cy of diagnosis of major depression in patients with pd 
evaluated with the updrs, and also to compare, for the 
same purpose, two self-reported scales for diagnosis of 
depression: the15-item shortened version of the Geriat-
ric depression scale (Gds15)6 and the Beck depression In-
ventory (BdI)7. 
METHOD
Fifty consecutive patients with idiopathic pd who attend-
ed a Brazilian Movement disorder Outpatient Clinic in ribeirão 
preto school of Medicine were evaluated. The inclusion criteria 
were a clinical diagnosis of pd8, absence of cognitive deficits as 
defined by the updrs, and sufficient educational level to be able 
to self-report properly the Gds15 and the BdI. patients were 
first evaluated by a neurologist who was not aware of the main 
purpose of the study. In a routine medical evaluation he classi-
fied the patients according to the updrs, Hoehn and Yahr stage 
(HY) and schwab and England (sE) scale. For motor assessment 
the examiner employed a shortened version of the updrs mo-
tor subscale with only 8 items. This shortened version scored the 
same signs evaluated by the short parkinson’s Evaluation scale9 
but with the original 5-point items of the updrs. This short-
ened scale was proven to have a good reliability and validity in 
Brazilian patients with pd10. After this evaluation, patients who 
met the inclusion criteria were required to self-complete the 
validated Brazilian versions of the Gds15 and the BdI11, 12. some 
help for the patient by the accompanying person was allowed if 
he requested some assistance. This procedure was completed in 
an isolated room without the presence of any medical person-
nel. All patients were evaluated while in the “on-state” if they 
were taking levodopa. After filling out the self-reported scales, 
patients were again evaluated by another neurologist who was 
unaware of the first neurological evaluation and of the patient’s 
scale scores. He was trained for, and conducted a free clinical in-
terview directed at the diagnoses of major depression according 
to the criteria of the diagnostic and statistical Manual of Men-
tal disorders, 4th edition (dsM-IV)13. All subjects underwent these 
sequential evaluations on the same day. Other demographic and 
clinical information were recorded for each patient such as sex, 
age, age at disease onset and duration of disease.
For statistical analysis, data from patients with major de-
pression according to dsM-IV criteria were compared to data 
from those without depression. Qualitative categorical variables 
were compared using the Chi-square test, while quantitative 
variables were analyzed by the Mann-Whitney test when the 
shapiro-Wilks test showed that they did not follow a normal dis-
tribution. We also looked for correlations using the spearman 
nonparametric correlation test. The diagnosis of major depres-
sion according to dsM-IV criteria was used as the gold-standard 
method. All scales were evaluated by their “receiver operating 
characteristics” curve (rOC curve) for identifying the single cut-
off point that better discriminates between depressed and non-
depressed patients. This study was approved by the local ethics 
committee and patients included in this study gave their in-
formed consent to participate.
Table 1. Demographic and clinical features of 50 consecutive patients with Parkinson’s disease (PD) 
screened for major depression according to the DSM-IV diagnostic criteria.
pd without depression pd with depression p
Number of patients 38 12
Taking antidepressive drugs 12 7
Male/Female 20/19
mean (sd)
6/5
mean (sd)
0.73
Age (years) 62.4 (12.6) 64.5 (12.7) 0.70
Age of pd onset (years) 54.5 (14.5) 56 (12.9) 0.84
pd duration (years) 7.9 (5.2) 8.4 (4.7) 0.63
shortened updrs motor score 12.57(9.51) 12.08 (7.50) 0.81
Hoehn and Yahr 2.1 (0.7) 2.4 (0.9) 0.05
schwab and England 78.8 (16.2) 73.7 (18.9) 0.39
depression item of the updrs 0.60 (0.91) 1.94 (1.54) <0.0001*
Gds15 4.65 (3.27) 11 (2.46) <0.0001*
BdI 12.6 (9) 26.5 (10.6) <0.0001*
sd, standard deviation; *significant difference (p<0.05); updrs, unified parkinson’s disease rating scale; Gds15, 15-
item Geriatric depression scale; BdI, Beck depression Inventory.
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RESUlTS
The clinical and demographic features of the 50 con-
secutive patients with pd evaluated are reported in Ta-
ble 1. We found 12 patients with actual diagnosis of ma-
jor depression according to the dsM-IV criteria, corre-
sponding to a prevalence of 24% in our sample. The diag-
nosis of major depression after the first neurological eval-
uation guided by the updrs had sensitivity (sEN) of 75% 
and specificity (spE) of 63%.
There were no significant differences between de-
pressed and non-depressed patients regarding sex dis-
tribution, age at disease onset, disease duration, Hoehn 
and Yahr (HY) stage, shortened updrs motor score and 
schwab and England (sE) functional scale. However, de-
pressed patients had significantly higher scores on all de-
pression scales: depression item of the updrs (p<0.0001), 
Gds15 (p<0.0001) and BdI (p<0.0001). 
Most patients did not report to be in trouble to self-
complete the depression scales, but one patient evolved 
to the off-state and was unable to fill out the BdI, and an-
other patient reported difficulties and refused to com-
plete the BdI. Only the latter patient was depressed. 
These patients were not excluded from analysis where 
the BdI were not included for comparisons.
We found a high correlation between disease dura-
tion, HY stage and sE functional scale (Table 2). The HY 
and sE scales were highly correlated with each other and 
with the updrs shortened motor score. Otherwise, the 
depression scales were highly correlated but did not have 
any correlation with the duration of the disease or with 
the other clinical scales for pd. We did not find any signif-
icant correlation for age, sex or age at pd onset.
The rOC curve analysis showed that the Gds15 curve 
had the closest approach to the left upper angle of the 
graph in comparison to the BdI curve, and that the Gds15 
curve approach had a single-pointed shape while the BdI 
curve approach was broadened without defining a sin-
gle optimal point. The last finding indicates that for the 
Gds15 it would be satisfactory to define only a single op-
timal cut-off score for the diagnosis and screening of de-
pression, while for the BdI it would be necessary to es-
tablish 2 distinct cut-off scores for each of these purpos-
es. The AuC was wider for the Gds15 (0.939) than for the 
BdI (0.918) (Figure).
The maximal discrimination between depressed and 
non-depressed patients was reached for Gds15 at the cut-
off score of 8/9 with sEN of 91% and spE of 92%, and for 
diagnostic purposes the best cut-off score was 10/11 with 
spE of 97% and predictive positive value (ppV) of 88%. For 
BdI, the maximal discrimination between depressed and 
non-depressed patients was reached at the cut-off score 
of 17/18 with sEN of 100% and a spE 76%, whereas for di-
Table 2. Correlations between Parkinson’s disease (PD) duration and clinical and depression scales.
disease
duration
Hoehn 
and Yahr
schwab and 
England
updrs 
motor score
Gds BdI updrs 
depression item
pd duration 1 0.55* –0.39* 0.11 0.12 –0.03 0.02
Hoehn and Yahr 0.55* 1 –0.75* 0.53* 0.26 0.22 0.03
schwab and England –0.38* –0.75* 1 –0.56* –0.26 –0.23 –0.11
updrs motor score 0.11 0.53* –0.56* 1 0.20 0.23 0.13
Gds15 0.12 0.26 –0.26 0.20 1 0.62* 0.38*
BdI –0.03 0.22 –0.23 0.23 0.62* 1 0.48*
updrs humor item 0.02 0.03 –0.11 0.13 0.38* 0.48* 1
*spearman correlation coeficient with p<0.05; any correlation found for age, sex and age of disease onset; updrs, unified parkinson’s disease rating 
scale; Gds15, 15-item Geriatric depression scale; BdI, Beck depression Inventory.
Figure. ROC curve (“receiver operating characteristics curve”) of the 
15-item Geriatric Depression Scale (GDS15) and of the Beck Depres-
sion Inventory  (BDI) depression scales for detecting major depres-
sion in patients with Parkinson’s disease according to DSM-IV crite-
ria. We can see that the area under the curve is wider for the GDS15 
which also had a single-pointed and closer approach to the left up-
per angle of the graph than the BDI curve.
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agnostic purposes the best cut-off score was 26/27 with 
spE of 95% and ppV of 80% .
DISCUSSION
We found a 24% prevalence of major depression in 
a group of 50 consecutive patients with pd attending a 
specialized outpatient clinic that is very similar to what 
was observed by studies assessing similar samples1,14,15. 
The routine clinical evaluation using the updrs showed 
moderate power to detect depression in pd (sEN of 75% 
and spE of 63%), considering that the clinicians were not 
specifically instructed to search for this clinical problem. 
Moreover, the updrs depression item was well correlated 
with the scores of the other depression scales, indicating 
that the subjective construct of depression generated by 
the clinician in a free clinical interview parallels that mea-
sured by these structured scales. These findings indicate 
a reasonable clinical competence to detect depressive 
symptoms in patients with major depression that is by no 
means close to satisfactory levels. However, 5/12 (45%) pd 
patients with depression were not in use of antidepressive 
drugs, suggesting that despite de correct diagnosis many 
patients are still left untreated.
We found that the scores of the Gds15 and BdI clearly 
differentiated depressed from non-depressed patients and 
were highly correlated, as was previously reported16. Our 
findings suggested that the Gds15 is better than the BdI 
for screening depression in patients with pd. The Gds15 
had a wider rOC curve indicating a higher discriminative 
property, and a more convenient approach to the left 
upper quadrant of the graph than the BdI. Other practi-
cal advantages of the Gds15 would be that it is shorter, 
easier and quicker to fill out than the BdI, none of the 
15 items being somatic, and is currently one of the most 
used depression self-reported scales in the old age17. Our 
findings for the BdI are closely similar to those obtained 
by Leentjens et al.15. The Gds15 and BdI are depression 
scales widely employed in Brazilian settings and validated 
versions are available. As we had showed, it is a useful 
strategy to employ self-reported scales as an alternative 
clinical approach to improve the diagnosis of depression 
in pd. Although there are no sufficient data to attain a 
consensus about the most proper scale to be used in pa-
tients with pd, we suggest that the Gds15 may be an ef-
fective alternative.
Considering that the profile of depressive symptoms 
in pd may differ from that in depressed subjects without 
pd18 and that some clinical manifestations of pd may be 
misinterpreted as somatic symptoms of depression, we 
would expect the optimal cut-off scores for screening 
depression in these patients would be distinct from that 
defined for the general population. However, our findings 
and other studies did not corroborate this assumption. 
For the BdI, it was described that the cut-offs ranged from 
15 to 20 in most studies conducted on the general popu-
lation19. This is very similar to that stipulated specifically 
for patients with pd: 13/14 by Leentjens et al.15, 17/18 by 
silberman et al.20, 14/15 by Visser et al.21, and 17/18 by our 
study. For the Gds15, community-based studies with el-
derly patients showed that the cut-off scores for screen-
ing depression ranged from 5 to 10 and in most of them 
between 5 or 6, with a sEN and spE around 90% and 70% 
respectively12,22-24. Our study defined that 8/9 was the 
best cut-off score for screening and diagnosing major 
depression in patients with pd, what is similar to those 
defined for the general population. We may conclude that 
the optimal cut-off scores for the BdI and Gds15 did not 
differ substantially for screening depression in the com-
munity or in patients with pd.
In our study, the level of depression was not correlated 
with the intensity of motor symptoms or with the func-
tional capacity as was previously reported by others25,26, 
and we did not find an association between the degree of 
depression and the duration of the disease. The lack of as-
sociation between motor and affective symptoms in pd is 
considered to be clinical evidence that depression may be 
induced by distinct pathophysiological mechanisms than 
those responsible for the motor signs. This hypothesis is 
supported by the findings that link depression in pd to a 
specific loss of serotonin, dopamine and noradrenalin in 
the limbic system but not to the striatal dopaminergic 
depletion27. Nevertheless, the association between motor 
and affective symptoms in pd is an unsolved matter, since 
other studies have found a relation between depression 
and the parkinsonian signs14,22,28. One possible explanation 
for our findings could be the fact that most of our pa-
tients were evaluated while they were under the effect 
of medication, so that their true clinical state was not 
manifest. Another point is that depression may be related 
to certain clinical aspects of the disease like the degree 
of bradykinesia or the presence of wearing-off phenom-
ena29. If there was a bias in sample selection, with a pre-
dominance of patients presenting with the rigid-akinetic 
form of pd or with motor complications, the study could 
be more prone to detect an association between motor 
signs and depression. In view of our current knowledge 
about depression in pd, it would be more suitable to re-
gard it as a complex and multifactorial problem that also 
includes situational and psychological factors taking part 
in the mechanisms that can elicit mood changes in the 
patients30. Appropriate studies are needed to address this 
controversial matter.
In conclusion, the use of self-reported scales improves 
the diagnosis of depression as given solely by the routine 
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clinical evaluation and the Gds15 is better than the BdI 
for screening depression in pd. The symptoms of depres-
sion in pd are not related to the degree of parkinsonian 
symptoms.
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